Novartis Ag (NVS) Net Cash Flow (2009 - 2025)

Novartis Ag (NVS) has 15 years of Net Cash Flow data on file, last reported at -$2.1 billion in Q4 2025.

• Quarterly Net Cash Flow rose 60.53% year-over-year to -$2.1 billion in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$3.8 billion (up 48.46% YoY) and the FY2025 annual result came in at -$600.0 million, up 63.33% from the prior year.
• Net Cash Flow fell to -$2.1 billion in Q4 2025 per NVS's latest filing, from -$860.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $15.8 billion in Q4 2023, with the low at -$10.2 billion in Q2 2022.
• Average Net Cash Flow over 5 years is -$1.2 billion, with a median of -$899.0 million recorded in 2024.
• Year-over-year, Net Cash Flow sank 886.32% in 2022 and surged 281.63% in 2023.
• Novartis Ag's Net Cash Flow stood at -$4.3 billion in 2021, then sank by 101.13% to -$8.7 billion in 2022, then surged by 281.63% to $15.8 billion in 2023, then tumbled by 133.77% to -$5.3 billion in 2024, then jumped by 60.53% to -$2.1 billion in 2025.
• Business Quant data shows NVS's Net Cash Flow at -$2.1 billion in Q4 2025, -$860.0 million in Q3 2025, and -$792.0 million in Q2 2025.